GlassScriptPhysician profile
Daniel S Haddad
NPI 1730157660
$4,402.70
in general payments reported to CMS, 2019-2025
19 companies · $285 in 2025
The $285 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,248 · 2020: $254 · 2021: $1,233 · 2022: $242 · 2023: $775 · 2024: $364 · 2025: $285.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877 · Consulting Fee: $513 · Gift: $36.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.75 |
| Consulting Fee | $512.50 |
| Gift | $36.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec, INC. | $1,361.14 | 2019-2024 | Iolmaster 700, Forum, Forum Glaucoma Workplace |
| Carl Zeiss Meditec USA, INC. | $1,243.68 | 2021-2025 | Forum, Visumax, Iolmaster 700 |
| Alcon Vision LLC | $344.12 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $198.55 | 2019-2021 | |
| Topcon Healthcare, INC. | $166.55 | 2021-2022 | |
| Ellexiscience | $148.25 | 2019 | |
| Kala Pharmaceuticals, INC. | $136.17 | 2020-2021 | |
| Allergan, INC. | $128.53 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $114.95 | 2019 | |
| Sun Pharmaceutical Industries INC. | $109.80 | 2022 | |
| Bausch Health US, LLC | $102.44 | 2020 | |
| Shire North American Group INC | $94.75 | 2019 | |
| Staar Surgical Company | $68.86 | 2019 | |
| Novo Nordisk INC | $62.87 | 2023-2024 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $38.94 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $26.10 | 2025 | Amo Phaco Needle |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb Americas INC. | $18.98 | 2023 | Vyzulta |
| Beaver-Visitec International, INC. | $18.62 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Haddad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.